mimoleculeindex.com
indexsame ingredientsame route
inspect molecule / rybelsus

Rybelsus

Semaglutide
  o==o
 /    \
 GLP1
 \____/

Semaglutide is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.

active moietySemaglutide
administration routeOral
price comparison status7 snapshots
safety signal rating78 / 100
GLP-1 Receptor Agonist [EPC]openFDA NDC seedopenFDA NDC14 mg/1
price index

Ingredient Reference Prices

⚠ Direct price snapshots for this brand/package are not staged yet. Showing verified reference prices for active ingredient: Semaglutide.
$918USvsCA$88CA

Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.

query trend --id 2648 --12m

Price Trend Index

Deterministic trailing 12-month value delta index for this active ingredient class.

Rising Fast3M: +2.6%12M: +0.4%
Jul 2025
▄▇███▆▃ ▂▅
Jun 2026
Jan 2026$893.17
Feb 2026$884.13
Mar 2026$880.60
Apr 2026$878.76
May 2026$889.07
Jun 2026$903.31
01 / chemistryNovo Nordisk Pharmaceutical Industries, LP

Ingredient Breakdown

active moietySemaglutide
formulationOral GLP-1 Receptor Agonist [EPC]
mechanism of action

GLP-1 Receptor Agonist [EPC]

available strengths
14 mg/1

label source: registry ↗

02 / ingredientsexcipients

Excipients / Maker Notes

  • Not enriched yet from label source.

Manufacturer Notes

  • This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals

Steps To Take Safely

  1. Confirm ingredient, dose, timing, food instructions, and interaction warnings with a clinician or pharmacist.
  2. Use the same ingredient name when comparing brand, generic, country, and pharmacy options.
  3. Do not split, crush, stop, or substitute extended-release products unless the label or clinician says so.
  4. Watch for severe allergic reactions, bleeding, mood changes, breathing issues, or other label-specific red flags.

Side-Effect Signals

  • nausea / vomiting
  • diarrhea or constipation
  • abdominal pain
  • low blood sugar risk with insulin/sulfonylureas
  • rare pancreatitis/gallbladder warning
Summary of index signals. Not active medical advice. Consult official labels and clinicians.

$ grep ingredient --same

Same Ingredient Sibling Records

All matches
OzempicWegovyRybelsusRybelsusWegovyWegovyWegovyWegovy